- Investigator
- Tung T Wynn
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Hemophilia A , 4 publications
- Factor VIII , 3 publications
- Recombinant Proteins , 3 publications
- Hemostasis , 2 publications
Research activity
Active clinical trials
Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of pediatric cancer patients living to adulthood, many pediatric cancer…
- Investigator
- Tung T Wynn
- Status
- Accepting Candidates
- Ages
- 5 Years - 14 Years
- Sexes
- All
- Investigator
- Tung T Wynn
- Status
- Accepting Candidates
My publications
Filter publications
17 publications
2022
Multidisciplinary Management of a Hemophilia A Patient Requiring Coronary Artery Bypass Graft Surgery
Journal of Cardiothoracic and Vascular Anesthesia
Publisher's site2022
Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
Blood
PubMed • Publisher's site2021
Preclinical development of plant-based oral immune modulatory therapy for haemophilia B.
Plant biotechnology journal
PubMed • Publisher's site2020
Bivalirudin and Alteplase for Pulmonary Embolism Requiring Veno-Arterial Extracorporeal Membrane Oxygenation in an Adolescent.
The journal of extra-corporeal technology
PubMed • Publisher's site2020
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.
Clinical pharmacokinetics
PubMed • Publisher's site